Wednesday, August 18, 2004 11:51:22 PM
I was under the impression that it pertained to exclusive rights and was a right of first refusal to actually own the product outright.
Obviously if DNAP doesn't offer the product then no one can exercise the option. On the other hand if they never offer a product, then the option will always be in play. Do you think DNAP is going to commercialize every product in house?
The concensus opinion a few years ago suggested that DNAP would use Retinome to force the option issue so that when Statnome was ready, the option would be out of the picture.
It will be interesting to see how the strategy plays out now.
regards,
frog
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM